Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference
BOULDER, Colo., Sept. 6, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2016 Morgan Stanley Global Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
| Event: |
Morgan Stanley Global Healthcare Conference |
||
| Presenter: |
Ron Squarer, Chief Executive Officer |
||
| Date: |
Wednesday, September 14, 2016 |
||
| Time: |
8:45 a.m. Eastern Time |
||
| Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
| CONTACT: |
Tricia Haugeto |
| Array BioPharma Inc. |
|
| 303-386-1193 |
|
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
SOURCE Array BioPharma
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article